EUVIMEDEUVIMED entdecken
Crossref

A ROS‐Responsive Injectable Hydrogel Platform Reprograms the Diabetic Wound Microenvironment to Enable Exosome Therapy

Zhiwei Shao, Qiao Wang, Rijian Song, Jingyu Zhang, Pengxu Chen, Roberto Garmondyu Reeves, Changbo Tao, Caiqi Shen, Mohammad Umar Farooq, Peisheng Jin, Aijun Zhang, Qiang Li

Advanced Healthcare Materials · 05.11.2026

DOI: 10.1002/adhm.71946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.11.2026. Verfasst von Zhiwei Shao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Construction Project of High Level Hospital of Jiangsu Province, Xuzhou Municipal Science and Technology Project: Clinical Cutting-Edge Technologies, Xuzhou Health Commission Youth Medical Science and Technology Innovation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic wounds persist because excessive reactive oxygen species (ROS) sustain chronic inflammation and disrupt the regenerative microenvironment, impairing the stability and function of bioactive therapeutic components, including stem cells and extracellular vesicles (EVs). Here, an injectable hyaluronic acid (HA) hydrogel integrates microenvironment modulation with regenerative cue delivery by co‐encapsulating ROS‐responsive cerium oxide nanozymes (CeO 2 NPs) and mesenchymal stem cell‐derived exosomes (EXOs). In this system, CeO 2 NPs act as antioxidant regulators that respond to oxidative stress, while EXOs provide regenerative signals for tissue repair. CeO 2 NPs are packaged within a thioketal‐linked PLGA‐PEG shell, enabling ROS‐triggered degradation and on‐demand activation, whereas the in situ crosslinked HA network serves as a localized matrix that protects components and synchronizes their sustained co‐release. Under high‐glucose conditions, the composite hydrogel reduces intracellular ROS, restores mitochondrial membrane potential, and enhances proliferation, migration, and angiogenic activity of endothelial cells and fibroblasts. In a diabetic mouse wound model, the hydrogel accelerates wound closure, accompanied by attenuated oxidative stress and inflammation, enhanced neovascularization and re‐epithelialization, organized collagen remodeling, and a shift of macrophages toward a pro‐regenerative M2 phenotype. This pathology‐responsive antioxidant–regenerative coupling strategy establishes a rational, modular platform for overcoming microenvironmental constraints in exosome‐based regenerative therapies.

Schlagwörter

Stichwörter der Autor:innen

cerium oxide nanozymesdiabetic woundexosomesinjectable hydrogelreactive oxygen species

Autor:innen und Institutionen

  • Department of Plastic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Xuzhou Medical University, Xuzhou, China.
  • Center for Cell Therapy and Regeneration Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Technology Innovation and Public Service Center, Huaihai Medical Science and Technology Innovation Center, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin, Ireland.
  • Institute of Precision Medicine, Anhui University of Science and Technology, Huainan, China.

Förderung

  • Construction Project of High Level Hospital of Jiangsu Province
  • Xuzhou Municipal Science and Technology Project: Clinical Cutting-Edge Technologies
  • Xuzhou Health Commission Youth Medical Science and Technology Innovation Project
  • General Program of Medicine and Health, Xuzhou Science and Technology Bureau

Zitieren

APA

Shao, Z., Wang, Q., Song, R., Zhang, J., Chen, P., Reeves, R. G., Tao, C., Shen, C., Farooq, M. U., Jin, P., Zhang, A., & Li, Q. (2026). A ROS‐Responsive Injectable Hydrogel Platform Reprograms the Diabetic Wound Microenvironment to Enable Exosome Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71946

Vancouver

Shao Z, Wang Q, Song R, Zhang J, Chen P, Reeves RG, et al. A ROS‐Responsive Injectable Hydrogel Platform Reprograms the Diabetic Wound Microenvironment to Enable Exosome Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71946

BibTeX
@article{Shao2026,
  author = {Shao, Zhiwei and Wang, Qiao and Song, Rijian and Zhang, Jingyu and Chen, Pengxu and Reeves, Roberto Garmondyu and Tao, Changbo and Shen, Caiqi and Farooq, Mohammad Umar and Jin, Peisheng and Zhang, Aijun and Li, Qiang},
  title = {A ROS‐Responsive Injectable Hydrogel Platform Reprograms the Diabetic Wound Microenvironment to Enable Exosome Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71946}
}
Kostenlos starten →